Manuscripts
Showing 1573 manuscripts.
4E10-Resistant HIV-1 Isolated from 4 subjects with Rare Membrane-Proximal External Region Polymorphisms
Citation
4E10-Resistant HIV-1 Isolated from 4 subjects with Rare Membrane-Proximal External Region Polymorphisms. PLoS One. 2010. 5: e9786. PMID: 20352106Year
          2010      
Journal
          PLoS One      
Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission
Citation
Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission. PLoS One. 2010. 5: e10213. PMID: 20422033Year
          2010      
Journal
          PLoS One      
Cross-contamination during processing of dried blood spots used for rapid diagnosis of HIV-1 infection of infants is rare and avoidable.
Citation
Cross-contamination during processing of dried blood spots used for rapid diagnosis of HIV-1 infection of infants is rare and avoidable.. Journal of Virological Methods. 2010. 163: 489-91. PMID: 19878694Year
          2010      
Journal
          Journal of Virological Methods      
Efficacy and safety of 1-month postpartum zidovudine and didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine.
Citation
Efficacy and safety of 1-month postpartum zidovudine and didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine.. Clinical Infectious Diseases. 2010. 50: 898-908. PMID: 20158398Year
          2010      
Journal
          Clinical Infectious Diseases      
HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells
Citation
HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells. Journal of Biomedical Science. 2010. 285: 1681-1691. PMID: 19917610Year
          2010      
Journal
          Journal of Biomedical Science      
Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV infected in utero
Citation
Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV infected in utero. AIDS. 2010. 24: 381-386. PMID: 19996936Year
          2010      
Journal
          AIDS      
Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda
Citation
Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda. Antimicrobial Agents and Chemotherapy. 2010. 54: 52-9. PMID: 19841149Year
          2010      
Journal
          Antimicrobial Agents and Chemotherapy      
Antiretroviral treatment for children with peripartum nevirapine exposure
Citation
Michael D Hughes, Avy Violari, Mark F Cotton, Raziya Bobat, Tammy Meyers, Mutsawashe Bwakura-Dangarembizi, Benjamin H Chi, Philippa Musoke, Portia Kamthunzi, Werner Schimana, Lynette Purdue, Susan H Eshleman, Elaine J Abrams, Linda Millar, Elizabeth Petzold, Paul Palumbo, Lynne M Mofenson, Jane C Lindsey, Patrick Jean-Philippe. Antiretroviral treatment for children with peripartum nevirapine exposure. New England Journal of Medicine. 2010. 363: 1510-1520. PMID: 20942667Year
          2010      
Journal
          New England Journal of Medicine      
Study
          P1060      
CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy
Citation
CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 2010. 54: 285-9. PMID: 19890215Year
          2010      
Journal
          Journal of Acquired Immune Deficiency Syndromes      
Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda
Citation
Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. AIDS Research and Human Retroviruses. 2010. 26: 563-568. PMID: 20455758Year
          2010      
Journal
          AIDS Research and Human Retroviruses